A Study of RE-021 in Patients With Focal Segmental Glomerulosclerosis
This study is not yet open for participant recruitment.
Verified July 2012 by Retrophin, LLC.
Sponsor:
Retrophin, LLC.
Information provided by (Responsible Party):
Retrophin, LLC.
ClinicalTrials.gov Identifier:
NCT01622738
First received: June 13, 2012
Last updated: July 24, 2012
Last verified: July 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is not yet open for participant recruitment. |
|---|---|
| Estimated Study Completion Date: | August 2014 |
| Estimated Primary Completion Date: | July 2014 (Final data collection date for primary outcome measure) |